Biocon informs about press release

21 Oct 2021 Evaluate

Biocon has informed that it enclosed the press release on October 21, 2021 titled ‘Biocon Biologics’ First-Ever Interchangeable Biosimilar Insulin Glargine, Co-Developed with Commercial Partner Viatris, Preferred on Express Scripts’ Largest Formulary in US’. The above information will also be available on the website of the Company at www.biocon.com.

The above information is a part of company’s filings submitted to BSE.

Biocon Share Price

384.55 5.50 (1.45%)
16-Jan-2026 11:30 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1674.90
Dr. Reddys Lab 1192.00
Cipla 1402.45
Zydus Lifesciences 882.00
Lupin 2204.55
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×